Brain-White Adipose Tissue Relationship: Early Features

This article is also available in Español and in Português

Author(s):

Luc Pénicaud PhD Luc Pénicaud
Dr. Pénicaud is Research Director at the Centre National de la
Recherche Scientifique (CNRS) since 1989.
View Author’s Full Biography

 

Central and autonomic nervous systems are involved in the regulation of whole body energy by regulating its different components: intake, expenditure and storage. The different functions (metabolic, secretory, plasticity) of adipose tissues are indeed deeply controlled by the autonomic nervous system. In most mammals, two types of adipose tissue, white and brown, are present. Both are able to store energy in the form of triacylglycerols and to hydrolyze them into free fatty acids and glycerol. Whereas white adipose tissue (WAT) provide lipids as substrates for other tissues, brown adipose tissue (BAT) uses fatty acids for heat production. Over a period of time, white fat mass reflects the balance between energy expenditure and energy intake. Remarkably body fat mass remains relatively constant in adult suggesting that food intake and energy expenditure are linked. This has been supported by numerous studies that demonstrated the inter-dependency of these parameters and thus a feedback loop between the brain and adipose tissues with the involvement of the autonomic nervous system on one side and that of sensory fibers and metabolites or hormonal signals on the other.

 

From the brain to white adipose tissue

Efferent innervation

It is well known that adipose tissues are innervated by sympathetic endings of the autonomic nervous system. It is currently recognized that brown adipose tissue is much more innervated than the white one.In WAT, catecholaminergic fibers have initially been reported as closely associated with the blood vessels (1, 2). However there are more and more data demonstrating direct neuro-anatomical innervation of white adipocytes. Although sparse, these sympathetic endings were of the “en passant” type thus allowing multiple sites of norepinephrine release. Using single neuron retrograde tracer and viral transynaptic tracing methodologies, the sympathetic outflow from brain to WAT has been identified. Altogether WAT receives input from central nervous system (CNS) cell groups that are part of the general SNS outflow from brain (hypothalamic nuclei, brainstem regions, intermedio-lateral cell groups of the spinal cord) (3, 4). More recently, Stanley and coworkers have elegantly demonstrated that most of neurons involved in the sympathetic input to WAT pads also projected to the liver, another key metabolically organ thus allowing a coordinated control of peripheral metabolism (5). There are striking differences between white and brown neuronal circuitry. First pseudorabies virus infections are much more marked after injections into BAT than into WAT, this could reflect the higher innervation of the former. Second, some areas were marked when the injection was performed in BAT but not when performed in WAT such as the lateral hypothalamus. The significance, if any, of these differences remains to be determined. Moreover, Bartness and al. demonstrated both shared and separate populations of brain, spinal cord, and sympathetic neurons innervating subcutaneous and visceral fat pad (6) (Figure 1). The main neurotransmitter of SNS is norepinephrine although these nerves contain and release various neurotransmitters among which neuropeptide Y (7). Both NE and NPY control lipolysis by activating different receptors subtypes present on adipocytes (8, 9). In WAT it has been demonstrated that the lipolytic activity of adipocytes depends on a balance between lipolysis-promoting ß-adrenergic receptor and lipolysis-inhibiting a2-adrenergic receptor (10, 11). Depending on this balance an increased sympathetic tone can lead to an increase or a decrease in lipolysis. For a long time it was thought that white adipose tissues did not received parasympathetic nerves. Recent neuro-anatomical studies in rats have reported parasympathetic innervation of WAT. A physiological role of such input was proposed since vagotomy was shown to reduce the insulin-dependent glucose and free fatty acid uptakes (12). Such role of PNS can be also sustained by the demonstration of the presence of functional nicotinic receptor on white adipocytes as well as an increased insulin sensitivity of these cells under nicotine stimulation (13). However the PNS innervation of WAT remains a subject of debates (14, 15).

 figure-1

Figure 1: Feedback loop between the brain and adipose tissues. The brain is informed of white and brown fat mass and their metabolic activity via sensory innervation and metabolic and hormonal signals traveling through the general circulation. Two main brain areas are involved in this detection the hypothalamus (Hypo) and the brain stem (NTS for Nucleus of the Tractus Solitarius). In turn the brain modulates adipose tissues activity via the autonomic nervous system mainly the sympathetic one.

 

 

Although adipose tissue is used as a general term, event the white-fat pads are quite different in regards of their origin, anatomical characteristics and functions so that one should rather speak about white adipose tissues. Indeed both autonomic innervation (fibers density or sub-location) and the number and affinity of neurotransmitter receptors of fat depots are heterogeneous. First a relatively separated sympathetic innervation of inguinal and epididymal pads exist, since there are no overlapping patterns of labeled postganglionic cells within the sympathetic chain innervating these two deposits using fluorescent tracers (3). In addition to this peripheral viscerotopic separation of sympathetic nerves, viscerotopy could also occur centrally, within spinal cord or brain (3, 12, 16, 17). Moreover, this heterogeneity of innervation may change according to nutritional, and probably other, status (18). Second, taking NE turn-over as an index of SNS activity, specific pattern has been delineated which might also depend of the stimulus considered (19). Altogether these last data indicate a higher lipolysis in intra-abdominal fat pads as compared to subcutaneous one. Third, this is reinforced by the distribution of the different subclasses of receptors that depends on species, sex, and fat depot (10, 20).

Effects of the autonomic nervous system on white adipose tissue functions

The two main metabolic pathways of adipocytes are on one hand the synthesis and accumulation of triglycerides and on the other their degradation into free fatty acid and glycerol (34). The increase in lipids store in adipocytes is performed by two ways. First by the direct uptake of triglycerides associated with lipoproteins coming from the circulation and which are hydrolized by lipoprotein lipase in non-esterified free fatty acids. These fatty acids are then transported into and in the cells by a family of fatty acid binding protein (FABP, FAT, FATP, aP2,….). Second by the lipogenic pathways i.e. the de novo synthesis from glucose. This last one is transported into the cell mainly via the insulin-sensitive glucose transporter isoform Glut 4. The glucose allows the synthesis of pyruvate and glycerol-3-phosphate, substrates, which will lead to the synthesis of triglycerides. Indeed, pyruvate will be utilized for the formation of acetyl-CoA and then its transformation into malonyl CoA under the control of acetyl-CoA carboxylase. The last step catalyzed by fatty acid synthase, a multienzyme complex, leads to the formation of long chain fatty acids. These anabolic pathways are mainly under the control of insulin. It is now recognized that lipolytic pathways is mainly under the dependency of three main players: adipose triglyceride lipase, hormone sensitive lipase, and perilipin A (21). In white adipocyte, both free fatty acids and glycerol are released into the adjacent blood vessels to provide fuel for other tissues. As already mentioned, catecholamines are the main factor involved in the control of lipolysis. However one has to underline that, the antilipolytic effect of insulin is predominant and thus catecholamines exert their effect when insulin level is low. From what is said above it is easy to conclude that the sympathetic nervous system is the main driver for adipose tissues lipolysis. Apart its well-known effect on lipolysis, sympathetic nervous system plays a role in regulating the anabolic pathways (10). Thus it has been shown that stimulation of sympathetic nerves has no main effect on glucose uptake, utilization and lipogenesis in WAT (22, 23). Whereas, as already mentioned, there are evidences that PNS innervation increases insulin sensitivity in WAT (12). Brown adipose tissue activity is mainly under the control of the sympathetic system via the binding of norepinephrine on beta adrenoceptor that induces lipolysis and thus the activity of UCP. This leads to an enhanced thermogenesis. Norepinephrine induces also an increase in the amount of UCP by stimulating its gene transcription (1). Over the last 20 years the notion has emerged that WAT is not only involved in the storage and release of energy but could also be part of other physiological functions due to its capabilities in synthesis and secretion of numerous factors such as leptin, adiponectin and many proteins involved in inflammation and immunity (24, 25). So that adipose tissue is now considered as a true endocrine organ. The synthesis and secretion of some of these compounds are under the control of numerous factors among which the sympathetic nervous system via catecholamines plays a role.  Leptin control has probably been the most studied. They are evidence that stimulation of ß-adrenoceptor decreases the release of leptin. In human adipose tissue this occurs through a posttranslational mechanism, most likely secretion per se. In contrast, in rat adipose tissue, isoproterenol does not affect basal leptin secretion but has a short-term action to antagonize the insulin-stimulated leptin biosynthesis (26). Also an elegant study demonstrates a decrease leptin secretion when 3T3L1 adipocytes (a well-characterized white adipose cell line) are cultured in the presence of primary sympathetic neurons. It has then been proposed that catecholamines may mediate short-term decrease in plasma leptin that occur within hours of fasting and cold exposure (27). Adiponectin is also negatively regulated by ß-adrenoceptor (28). By contrast the secretion of cytokines such as TNFa and IL6 are increased under ß-adrenergic stimulation (29).  Overall these data suggest that up-regulation of pro-inflammatory cytokines and down-regulation of adiponectin by ß-adrenoceptor activation may contribute to the pathogenesis of catecholamine-induced insulin resistance.

Effects of the autonomic nervous system on WAT growth

Fat mass is the result of two processes i.e. the regulation of the size and the number of adipocytes. There are also numerous evidence showing that the SNS is involved in the control of proliferation and differentiation and to a lesser extend of apoptosis of white adipocytes. Norepinephrine inhibits proliferation of adipocyte precursor cells in vitro and this can be blocked by propranolol, a general ß-adrenoceptor antagonist (30). In vivo surgical or pharmacological denervation of WAT triggers significant increase in the number of white preadipocytes and adipocytes (4, 23). One week after denervation of one retroperitoneal fat pad, DNA content is increased without change in the number of mature white adipocytes. Furthermore, the amount of A2COL6, an early marker of white adipocyte differentiation is enhanced in the denervated pad. One month later, the number of mature adipocytes is significantly increased in the denervated pad (23). This was confirmed using transgenic mice having a massive reduction of innervation due to the lack of Nscl-2, a neuronal specific transcription factor (31). These mice present an increase preadipocytes number and a bimodal distribution of the size of adipocytes indicating an increase in the number of small adipocytes. Moreover, recent data demonstrates that increase in sympathetic drive to WAT pads may induce emergence of brown (or brown-like) adipocytes within WAT depots, an effect likely due to eta3 receptors activation (32, 33). Altogether, these data agree with a major role of SNS. Nevertheless, one must keep in mind that sympathetic efferent fibers synthetize and release other neurotransmitters such as NPY. Indeed, it has been demonstrated that sympathetic NPY release stimulates fat angiogenesis, proliferation and differentiation of new adipocytes, resulting in adipose tissue growth (55, 56). These effects which are mediated through Y1 and/or Y2 receptor subtypes can thus antagonize or minimize NE effects (34) (Figure 2). figure-2

Figure 2: Control by the sympathetic nervous system of white adipocyte proliferation and differentiation.   

 

 

Although the importance of apoptosis in the biology of adipose tissues is still a controversial issue, there are different reports describing such process in white adipocytes. To our knowledge there is no direct demonstration of a role of the SNS in regulating the rate of apoptosis in adipose tissues, however several observations are in support of such role. In brown adipocytes, the pro-apoptotic effect of TNFa is abrogated by NE and this neurotransmitter protects the cells from apoptosis (35). Nothing is known concerning such effects on white adipose cells. Nevertheless, leptin is indeed known to induce a reduction in fat pads weight, this effect being observed after peripheral or central injection. Furthermore adipocyte apoptosis occurs after intracerebroventricular administration of leptin in rats (35). On the other hand it is well demonstrated that leptin induces an increased SNS activity (37, 38). From these data, it can be proposed that the signal that promotes apoptosis under leptin CNS activation is probably NE or another co-secreted neurotransmitter.

 

From adipose tissues to the brain

Circulating signals

Energy balance is the result of ingestive behavior, energy expenditure and energy storage in adipose tissue. To explain the precise overall regulation of these parameters it has been hypothesized, at first by Kennedy in the 50th, that signals generated in proportion to body fat stores will act in the brain to modulate food intake and/or energy expenditure (39). Among these signals the first to be proposed was insulin; since it was demonstrated that the pancreatic hormone increases proportionally to body fat mass and acts in the CNS to reduce food intake (40). In the nineties, Friedman and his colleagues identified leptin and its receptors (41). Leptin is predominantly expressed in adipose tissue and the long form of its receptor (ob-Rb) is highly expressed in specific sites within the CNS. As expected, administration of leptin reduced food intake and body in different animal-models of obesity as well as in humans. Leptin is secreted in direct proportion to the amount of stored body fat (42). As a consequence plasma leptin concentration increases while body fat rises whereas fasting and leanness lead to decreased leptin secretion. Since the discovery of leptin other factors synthesized and released by adipocytes have been characterized and are grouped under the term adipokines (Figure 1). Among them, adiponectin, nesfatin, visfatin as well as cytokines such as IL6, TNFlpha have been shown to be involved in energy homeostasis partly via their action in the brain (43). Adiponectin is the most abundant protein secreted by white adipose tissue (44). The protein is found in the cerebro spinal fluid (45). Its receptors are present in neurons of the hypothalamus known to control food intake and energy expenditure (45, 46). Adiponectin injected icv increases energy expenditure and reduces food intake (45, 47). Nesfatin (NEFA/nucleobinding2-encoded satiety-and fat-influencing protein) is an adipokine having strong anorectic effect by acting centrally (48, 49). It mainly interacts with the melanocortin system. It is synthetized by different tissues among which WAT but is also present in the CNS (48). Visfatin is mainly synthesized by visceral fat although its expression is not restricted to WAT (50). It has an orexigenic effect and a positive correlation exists between plasma visfatin level and body fat mas and body weight in human (51). TNFa and IL6 are secreted by adipose tissues but the main source is not the adipocyte itself but rather macrophages (52). Their release is proportional to the amount of fat and their anorectic effect has been demonstrated since many years (53). Last, one has also to stress the role of nutrients of which the concentration might depend on the metabolic activity of adipose tissues such as glucose and particularly free fatty acids. Indeed both of these metabolites have been shown to play an important role as signals, reflecting energy homeostasis, to some part of the brain (54, 55). Glucose and lipids are detected by specialized fuel-sensing neurons that are incorporated in specific hypothalamic neuronal circuits. Hence, circulating nutrients cooperate with hormones (insulin) and adipokines (mainly leptin) to regulate the activity of distinct neuronal populations that control food intake, energy expenditure, and glucose homeostasis.

Sensory innervation

Apart these circulating signals acting directly in the hypothalamus and other areas, adipose tissues sensory nerves may be part of this system. The identification of substance P and calcitonin gene-related peptide, markers of sensory neurons was a first demonstration of sensory innervation of WAT (7). Then a direct neuroanatomical demonstration was given by use of anterograde tracer (56). Labelled cells were found at all levels of the neuroaxis: nodose ganglia (visceral afferents), dorsal horn of the spinal cord (nociceptive and/or proprioceptive afferents) and in almost all the autonomic outputs areas in the brainstem and midbrain” (13, 57) (Figure 1). Although one does not know which molecules (leptin, lipid molecules such as glycerol, free fatty acids, prostaglandins) these nerves “sense”, data are in support of their role in informing the brain on lipid stores. When selective an bilateral destruction of sensory fibers innervating epidydimal fat pad was performed in hamster by injecting capsaicin, the weight of the others WAT pads (retroperitoneal and inguinal) was increased in a degree that approximated the lipid deficit if the pads have been removed by lipectomy (58). Second, leptin microinjection in WAT pad significantly increased electrical activity of sensory afferent neurons emanating from the pad and elicited increase in sympathetic efferent neurons in the contra-lateral pad suggestive of a reflex arc (59).

Autonomic nervous system and obesity

As described above, in white adipose tissue, an increased sympathetic tone will slow down proliferation and differentiation and might also enhance apoptosis. By contrast in brown adipose tissue, there is an increased proliferation and differentiation and possibly a reduction of brown adipocytes apoptosis all phenomenon leading to higher thermogenic capacity (Figure 3). figure-3

Figure 3: Involvement of the autonomic nervous system in obesity. Decreased sympathetic activity  can explain development of abnormal fat mass. This decrease results in a lower thermogenic activity and growth of brown adipose tissue which lead to a decreased energy expenditure. It also drives a higher proliferation and differentiation of white adipocytes which together with a decreased lipolysis will result in a higher fat mat.

 

 

As a consequence, dysregulation of the sympathetic nervous tone can play a role in some pathological situations. Such can be the case in obesity at least in rodents and possibly in adult human in which a decreased sympathetic activity has been described (61-64). Although there are some opposite results in man which might be due to the characteristic of the subjects as well as the methods used (65). Although scarce, there are a recent study showing a decreased sympathetic activity in childhood obesity (66). Such a decrease will lead, in white adipose tissue, to the disappearance of the inhibition of adipocytes proliferation and differentiation normally found in lean rats. This would result in the recruitment of new precursors and the appearance of new adipocytes. Together with decreased lipolysis and the influence of hyperinsulinemia that will favor hypertrophia of both pre-existing and new cells (61), will lead to over-development of this tissue. On the other hand, a decrease sympathetic tone will result in an overall decreased thermogenesis by first decreasing the amount and the activity of UCP1, second lowering the number of brown adipocytes. This last point can be due to both decreased proliferation and differentiation, increased apoptosis and although possible changes from one phenotype to the other (61, 67, 68).

 

Conclusions

In summary there are compelling evidences of the importance of the nervous regulation of the adipose mass, either brown or white, by acting on the metabolic and secretory activities but also on the plasticity (proliferation, differentiation, trans-differentiation, apoptosis) of these tissues.The neural feedback-loop between adipose tissues and the brain plays a crucial role in numerous physiological phenomena in particular the regulation of energy homeostasis and body fat mass but also reproduction and immune function. This loop could be altered in various metabolic pathologies such as obesity, type II diabetes and their complications.

 

References

  1. Himms-Hagen J. Brown adipose thermogenesis: interdisciplinary studies. FASEB J 1990; 4: 2890-8
  2. Slavin BG, Ballard KW. Morphological studies of the adrenergic innervation of white adipose tissue. Anta Rec 1978; 191: 377-89
  3. Bamshad M, Aoki VT, Adkison MG et al. Central nervous system origins of the sympathetic system outflow to white adipose tissue. Am J Physiol 1998; 276: R291-9.
  4. Bowers RR, Festuccia WTL, Song CK et al. Sympathetic innervation of adipose tissue and its regulation of fat cell number. Am. J Physiol 2004; 286: R1167-75.
  5. Stanley S, Pinto S, Segal J et al. Identification of a neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically. Proc Natl Acad Sci 2010; 107: 7024-9.
  6. Nguyen NL, Randall J, Banfield BW, Bartness TJ. Central sympathetic innervations to visceral and subcutaneous white adipose tissue. Am J Physiol 2014; 306: R375-86.
  7. Giordano A, Morroni M, Santone G et al. Tyrosine hydroxylase, neuropeptide Y, substance P, calcitonin gene-related peptide and vasoactive intestinal peptide in nerves of rat periovarian adipose tissue: an immunohistochemical and ultrastructural investigation. J Neurocyto 1996; 25: 125-36.
  8. Castan I, Valet P, Quideau N et al. Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes. Am J Physiol 1994; 266: R1141-7.
  9. Serradeil-Le Gal C, Lafontan M, Raufaste D et al. Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes. FEBS Lett 2000; 475: 150-6.
  10. Lafontan M, Berlan M. Fat cell adrenergic receptor and the control of white and brown fat cell function. J Lipid Res 1993; 34: 1057-91.
  11. Grujic D, Susulic VS, Harper ME et al. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 1997; 272: 17686-93.
  12. Kreier F, Fliers E, Voshol PJ et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J Clin Invest 2002; 110: 1243-50.
  13. Liu RH, Mizuta M, Matsukura S. The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. JPET 2004; 310: 52-8.
  14. Berthoud HR, Fox EA, Neuhuber W . Vagaries of adipose tissue innervation. Am J Physiol 2006; 291: R1240-2.
  15. Kreier F, Buijs RM. Evidence for parasympathetic innervation of white adipose tissue, clearing up some vagaries. Am J Physiol 2007; 293: R548-9.
  16. Brito MN, Brito NA, Baro DJ, Song CK, Bartness TJ. Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 2007; 148:5339-47.
  17. Kreier F, Kap YS, Mettenleiter TC et al. Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinol 2006; 147: 1140-7.
  18. Giordano A, Frontini A, Murano I et al. Regional-dependent increase of sympathetic innervation in rat white adipose tissue during prolonged fasting. J Histochem Cytochem 2005; 53: 679-87.
  19. Brito NA, Brito MN, Bartness TJ. Differential sympathetic drive to adipose tissues after food deprivation, cold exposure or glucoprivation. Am J Physiol 2008; 294: R1445-52.
  20. Mauriège P, Galitzky J, Berlan M, Lafontan M. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences.  Eur J Clin Invest 1987; 17: 156-165.
  21. Wang S, Soni KG, Semache M et al. Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab 2008; 95: 117-26.
  22. Shimazu T, Sudo M, Minokoshi Y, Takahashi A. Role of the hypothalamus in insulin  dependent glucose uptake in peripheral tissues. Brain Res Bull 1991; 27: 501-4.
  23. Cousin B, Casteilla L, Lafontan M et al. Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism.  Endocrinology 1993; 33: 2255-62.
  24. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008; 37: 753-68.
  25. Pénicaud L, Cousin B, Laharrague P et al. Adipose tissues as part of the immune system: role of leptin and cytokines. In Kordon C, Robinson I, Hanoune J, Dantzer R, Christen Y eds. Brain somatic cross-talk and the central control of metabolism. Springer Verlag 2002; 81-87.
  26. Ricci MR, Lee MJ, Russell CD et al. Isoproterenol decreases leptin release from rat and human adipose tissue through posttranscriptional mechanisms. Am J Physiol 2005; 288: E798-804.
  27. Lee MJ, Fried SK. Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. Am J Physiol Endocrinol Metab 2009; 296: E1230-8.
  28. Fu L, Isobe K, Zeng Q et al. Beta-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-alpha expression in adipocytes. Eur J Pharmacol 2007; 569: 155-62.
  29. Vicennati V, Vottero A, Friedman C, Papanicolaou DA. Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord 2002; 6: 905-11.
  30. Jones DD, Ramsay TG, Hausman GJ, Martin RJ. Norepinephrine inhibits rat pre-adipocyte proliferation. Int J Obes 1992; 16: 349-54.
  31. Ruschke K, Ebelt H, Klöting N et al. Defective peripheral nerve development is linked to abnormal architecture and metabolic activity of adipose tissue in Nscl-2 mutant mice. PLoS One 2009; 4: e5516.
  32. Cao L, Choi EY, Liu X et al. White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab 2011; 14: 324-38.
  33. Jimenez M, Barbatelli G, Allevi R, Cinti S et al. B3-adrenoceptor knockout in C57BL/6J mice depresses the occurence of brown adipocytes in white fat. Eur J Biochem 2003; 270: 699-705.
  34. Kuo LE, Kitlinska JB, Tilan JU et al.  Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nature Med  2007; 13: 803-11.
  35. Nisoli E, Briscini L, Tonello C et al. Tumor necrosis factor-alpha induces apoptosis in rat brown adipocytes. Cell Death Differ 1997; 4: 771-8.
  36. Hamrick MW, Della Fera MA, Choi YH et al. Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow. Cell Tissue Res 2007; 327: 133-41
  37. Haque MS, Minokoshi Y, Hamai M, et al. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes 1999; 48: 1706-12.
  38. Scarpace PJ, Matheny M. Leptin induction of UCP1 gene expression is dependent on sympathetic innervation. Am J Physiol 1998; 275: E259-64.
  39. Kennedy GC (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond 140: 578-96.
  40. Porte D Jr, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 2005; 54: 1264-76.
  41. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
  42. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal- weight and obese humans. New Engl J Med 1996; 334: 292-5.
  43. Schulz C, Paulus K, Lehnert H. Adipocyte-brain : crosstalk. Results Probl Cell Differ 2010; 52: 189-201.
  44. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439–51.
  45. Kubota N, Yano W, Kubota T, et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007; 6: 55–68.
  46. Guillod-Maximin E, Roy AF, Vacher CM, et al. Adiponectin receptors are expressed in hypothalamus and colocalized with pro-opiomelanocortin and neuropeptide Y in rodent arcuate neurons. J Endocrinol 2009; 200: 93–105.
  47. Qi Y, Takahashi N, Hileman SM, Patel HR, et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10: 524–9.
  48. Oh-I S, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443: 709–12.
  49. Shimizu H, Oh I, Hashimoto K, et al. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009; 150: 662–71.
  50. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426–30.
  51. Hallschmid M, Randeva H, Tan BK, et al. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes 2009; 58: 637–40.
  52. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol. Cell Endocrinol 316: 129-39.
  53. Dantzer R, Bluthé RM, Gheusi G, et al. Molecular basis of sickness behavior. Ann NY Acad Sci 1998; 856: 132-8.
  54. Pénicaud L, Leloup C, Fioramonti X, et al. Brain glucose sensing: a subtle mechanism. Curr Opin Clin Nutr Metab Care 2006; 9: 458-62.
  55. Belgardt BF, Brüning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 2010; 1212: 97-113.
  56. Fishman RB Dark J. Sensory innervation of white adipose tissue. Am J Physiol 1987; 253: R042-4.
  57. Song CK, Schwartz GJ, Bartness TJ. Anterograde transneuronal viral tract tracing reveals central sensory circuits from white adipose tissue. Am J Physiol 2009; 296: R501-11.
  58. Shi H, Bartness TJ. White adipose tissue sensory nerve denervation mimics lipectomy-induced compensatory increases in adiposity. Am J Physiol 2005; 289: R514-20.
  59. Niijima A. Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat. J Auton Nerv Syst 1998; 73: 19-25.
  60. Murphy KT, Schwartz GJ, Nguyen NL, Mendez JM, Ryu V, Bartness TJ. Leptin-sensitive sensory nerves innervate white fat. Am J Physiol 2013; 304 : E1338-47.
  61. Pénicaud L, Cousin B, Leloup C et al. Changes in autonomic nervous system activity and consecutive hyperinsulinemia: respective roles in the development of obesity in rodents. Diabetes Metabolism 1996; 22: 15-24.
  62. Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA. Body fat and the actiity of the autonomic nervous system. N Engl J Med 1998 ; 318 : 1077-83.
  63. Spraul M, Ravussin E, Fontvieille et al. Reduced sympathetic nervous activity. A potential mechanism predisposing to weight gain. J Clin Invest 1993; 92: 1730-5.
  64. Tataranni PA, Young JB, Bogardus C, Ravussin E. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes Res 1997; 5: 341-7.
  65. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Ciculation 2002; 106: 2533-6.
  66. Baum P, Petroff D, Classen J, Kiess W, Blüher S.  Dysfunction of autonomic nervous system in childhood obesity: a cross-sectional study. PLoS One. 2013; 8:e54546.
  67. Cousin B, Cinti S, Morroni M, et al. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Science 1992; 103: 931-42.
  68. Giralt M, Villarroya F. White, brown, beige/brite : different adipose cells for differnet functions ? Endocrinology. 2013; 154:2 992-3000.

 

 

0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

Send this to a friend